Arid1a loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression

HIGHLIGHTS

• who: Ni Li from the Human tumor samples and TMA analysis The use of pathological specimens, as well as the review of all pertinent patient records, was approved by the ethical standards of the institutional research committee and with the , Declaration of Helsinki and its later amendments or comparable ethical standardsAll patient samples were collected by the Department of Pathology with approval from the Research Ethics Committee of Daping Hospital, Army Medical University, and informed consent was obtained from the patients. To determine the correlation of ARID A expression, NF-u03baB signaling activity and protein levels of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.